Summary of Research and Developments in Macular Degeneration, 2011-2012

by Dan Roberts June 2012 Introduction Here is MD Support’s summary of the the past twelve months of significant research and development in the field of macular degeneration. We begin with the field that has been making the most news: pharmacology. _______________________________ PHARMACOLOGY SEP: Infection Risk From Repackaged Avastin The big pharmaceutical news of the [Read More]

siRNA Turns Off Bad Genes

by Dan Roberts (updated April 2009) A new type of anti-VEGF drug called “small interference RNA (siRNA),” is showing promise in its ability to turn off genes that cause wet AMD. A preliminary primate study in early 2004 showed that, at the highest dose used in the study siRNA (formerly called RNAi) “reduced the incidence [Read More]

Summary of Research and Developments in Macular Degeneration: 2005-2006

by Dan Roberts This is a compilation of significant research in the field of macular degeneration during the period May 2005 through May 2006, beginning with new findings as presented at the 2006 meeting of the Association for Research in Vision and Ophthalmology (ARVO). Triple therapy found to be effective for wet AMD Triple therapy [Read More]